Quantification using cellomics demonstrated a slightly higher proportion of calbindin+ cells in the ADL condition (30.9 ± 10.5%) compared to both AD (21.9 ± 10.7%) and A condition (23.8 ± 5.7%) (Figure 3B). Here, CALB1 is linked to Alzheimer disease.